BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    BD POSIFLUSH¿ XS PRE-FILLED FLUSH SYRINGE NACL 0.9%

    MDR report key: 8440352 · Received March 21, 2019

    Report

    Report Number
    9616657-2019-00158
    Event Type
    Malfunction
    Date Received
    March 21, 2019
    Date of Event
    December 29, 2018
    Report Date
    April 5, 2019
    Manufacturer
    BECTON, DICKINSON AND CO.
    Product Code
    NGT
    PMA / PMN Number
    N/A
    Adverse Event
    Yes
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    UK
    Reporter Occupation
    OTHER HEALTH CARE PROFESSIONAL

    Narratives

    Additional Manufacturer Narrative · 0

    THE NON-CONFORMANCES WERE REVIEWED FOR THIS BATCH, AND THERE WAS NO RECORD OF NON-CONFORMANCE WHICH COULD CONTRIBUTE TO THE COMPLAINT VERBATIM REPORTED BY THE CUSTOMER. NO SAMPLE AVAILABLE. THERE IS NO EVIDENCE THAT POSIFLUSH SYRINGE WAS RESPONSIBLE FOR THIS REACTION. A POTENTIAL CONTRIBUTORY FACTOR MAYBE OTHER MEDICINAL PRODUCTS IN USE OR ADMINISTERED AT THE TIME THE PATIENT¿S PORT WAS FLUSHED. BASED ON THE INFORMATION PROVIDED, IT IS MORE PROBABLE THAN NOT THAT THE SYMPTOMS DESCRIBED MAY BE AN ALLERGIC REACTION; HOWEVER, IT IS HIGHLY IMPROBABLE THAT THIS REACTION WAS PRODUCED BY THE NORMAL SALINE IN THE BD POSIFLUSH PRODUCT. DURING THE PERIOD 2017-2019, THERE ARE NO OTHER ADVERSE CUSTOMER COMPLAINT TRENDS FOR THE COMPLAINT CATEGORY OF ALLERGIC REACTION, APART FROM FRESENIUS KABI UK. THERE ARE NO KNOWN ALLERGIES TO NORMAL SALINE, EITHER TOPICAL OR WITHIN THE BODY. IT IS MOST LIKELY THAT WHATEVER FLUID WAS IN THE IV LINE PRIOR TO FLUSHING CONTAINED INADEQUATELY FLUSHED MEDICATION OR GLUCOSE FROM PREVIOUS TREATMENTS. H3 OTHER TEXT : SEE SECTION H.10

    Description of Event or Problem · 0

    IT WAS REPORTED THAT A BD POSIFLUSH¿JAVASCRIPT:RESIZEFLEXELEMENT('DESCRIBE EVENT OR PROBLEM', 'DESCRIBE EVENT OR PROBLEM', FALSE, FALSE) XS PRE-FILLED FLUSH SYRINGE NACL 0.9% WAS INVOLVED WITH A PATIENT THAT RECEIVED NUTRITION INFUSIONS, EXPERIENCING PAIN AND NAUSEA FROM THE INFUSIONS. THE FOLLOWING WAS REPORTED, " WE HAVE RECEIVED AN ADVERSE EVENT REPORTED ON 29 DEC 2018 AND 13 JAN 2019 TO ADVISE PATIENT UNWELL; NAUSEA. NURSE REPORTED PATIENT HAS LONG STANDING ISSUES OF EXPERIENCING PAIN AND NAUSEA FROM PARENTERAL NUTRITION INFUSIONS, PATIENT ADVISED TO SEEK ADVICE FROM HOSPITAL; NO FURTHER INFORMATION OBTAINED.

    Additional Manufacturer Narrative · 1

    THERE WERE MULTIPLE LOT NUMBERS REPORTED TO BE INVOLVED. THE INFORMATION FOR EACH LOT NUMBER IS AS FOLLOWS: MEDICAL DEVICE LOT #: 8242797. MEDICAL DEVICE EXPIRATION DATE: 2021-08-31. DEVICE MANUFACTURE DATE: 2018-08-30. MEDICAL DEVICE LOT #: 8270683. MEDICAL DEVICE EXPIRATION DATE: 2021-08-31. DEVICE MANUFACTURE DATE: 2018-09-27. (B)(6). A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

    Description of Event or Problem · 1

    IT WAS REPORTED THAT A BD POSIFLUSH¿JAVASCRIPT: RESIZEFLEXELEMENT ('DESCRIBE EVENT OR PROBLEM', 'DESCRIBE EVENT OR PROBLEM', FALSE, FALSE) XS PRE-FILLED FLUSH SYRINGE NACL 0.9% WAS INVOLVED WITH A PATIENT THAT RECEIVED NUTRITION INFUSIONS, EXPERIENCING PAIN AND NAUSEA FROM THE INFUSIONS. THE FOLLOWING WAS REPORTED, WE HAVE RECEIVED AN ADVERSE EVENT REPORTED ON (B)(6) 2019 TO ADVISE PATIENT UNWELL; NAUSEA. NURSE REPORTED PATIENT HAS LONG STANDING ISSUES OF EXPERIENCING PAIN AND NAUSEA FROM PARENTERAL NUTRITION INFUSIONS, PATIENT ADVISED TO SEEK ADVICE FROM HOSPITAL; NO FURTHER INFORMATION OBTAINED.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    232342 BD POSIFLUSH¿ XS PRE-FILLED FLUSH SYRINGE NACL 0.9% PRE-FILLED SYRINGE NGT BECTON, DICKINSON AND CO. SEE H.10

    Patients

    Seq Age Sex Outcome Treatment
    1 Required Intervention